arginine has been researched along with Bladder Cancer in 44 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 27 (61.36) | 18.7374 |
1990's | 4 (9.09) | 18.2507 |
2000's | 2 (4.55) | 29.6817 |
2010's | 5 (11.36) | 24.3611 |
2020's | 6 (13.64) | 2.80 |
Authors | Studies |
---|---|
Alsyouf, M; Daneshmand, S; Djaladat, H | 1 |
Chen, S; Chen, X; Chen, Y; Cheng, L; Dong, W; Huang, J; Huang, M; Li, W; Lin, T; Peng, S; Su, Q; Wu, J; Xie, R; Yao, K; Zhang, Q; Zhou, Q | 1 |
Fan, W; Lai, WF; Liu, Y; Liu, Z; Ma, M; Qi, X; Qin, X; Sun, L; Wang, H; Wang, S; Zhang, D; Zhang, H; Zhang, P; Zheng, B | 1 |
Kong, C; Liu, S; Liu, X; Liu, Z; Piao, C; Yin, L; Zhang, Z | 1 |
Cheng, PN; Ho, JC; Ke, C; Li, W; Liu, Y; Wang, D; Xu, S; Zhang, P; Zhao, Z | 1 |
Hannah, P; Khaleel, S; Konety, B; Regmi, S; Sathianathen, N; Watarai, B; Weight, C | 1 |
Davies, BJ; Gingrich, JR; Hrebinko, RL; Jacobs, BL; Lyon, TD; McBride, D; Tarin, TV; Turner I I, RM; Wang, L | 1 |
Bechtel, MD; Carlson, SE; Chalise, P; Hamilton-Reeves, JM; Hand, LK; Holzbeierlein, JM; Hull, H; Lee, EK; Mirza, M; Smelser, W; Stanley, A; Wyre, H; Yankee, TM | 1 |
Field, HI; Hamamoto, R; Hayami, S; Kelly, JD; Maehara, Y; Nakamura, Y; Neal, DE; Ponder, BA; Toyokawa, G; Tsunoda, T; Unoki, M; Yoshimatsu, M | 1 |
Afroze, D; Khan, NP; Pandith, AA; Rasool, R; Shah, ZA; Siddiqi, M; Wani, S; Yousuf, A | 1 |
Xia, YC; Xiao, P; Yuan, XK; Zhao, XK; Zhu, X | 1 |
Closs, EI; Habermeier, A; Martiné, U; Plies, L; Reining, M; Simon, A | 1 |
Ivanov, V; Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
Andreesen, R; Konur, A; Krause, SW; Kreutz, M; Rehli, M | 1 |
Adolfsson, J; Jansson, OT; Kratz, G; Morcos, E; Wiklund, NP | 1 |
Blanck, G; Eason, DD; Shepherd, AT | 1 |
Płuzańska, A; Robak, T | 1 |
Dalesio, O; De Pauw, M; Denis, L; Robinson, M; Schulman, CC; Smith, P; Sylvester, R; Viggiano, G | 2 |
Lum, BL | 1 |
Ingargiola, GB; Pavone-Macaluso, M; Tripi, M | 1 |
Dalesio, O; Glashan, R; Green, DF; Newling, D; Robinson, MR; Smith, PH | 1 |
Lum, BL; Torti, FM | 1 |
de Pauw, M; Fosså, SD; Mulder, JH; Stoter, G; van Oosterom, AT | 1 |
Soloway, MS | 1 |
Baumgartner, G | 1 |
Hofmann, W; Langkopf, B | 1 |
Abbou, C; Auvert, J; Botto, H; Garcia-Giralt, E; Hannoun, M; Jouve, M; Lachand, AT; Morin, P; Palangie, T; Pouillart, P | 1 |
El-Morsi, B; El-Sebai, IT; Gad-el-Mawla, NM; Hamza, MR; Khafagy, M; Mansour, MA; Muggia, FM; Sherif, M | 1 |
Sherif, M | 1 |
Pavone-Macaluso, M | 1 |
De Pauw, M; Denis, L; Lachand, A; Pavone-Macaluso, M; Robinson, M; Schulman, C; Smith, P; Staquet, M; Sylvester, R | 1 |
Henney, JE; Muggia, FM; Rozencweig, M; Von Hoff, DD | 1 |
Caramia, G; Messana, V; Pavone-Macaluso, M; Rizzo, FP | 1 |
Kenis, Y; Rozencweig, M; Schulman, CC; Staquet, M; Sylvester, R | 1 |
Mechl, Z; Rovný, F; Sopková, B | 1 |
Ingargiola, GB; Pavone-Macaluso, M; Serretta, V | 1 |
Carbone, A; Carmignani, G; Dal Bo, V; Francini, M; Lo Re, G; Magri, MD; Merlo, A; Morassut, S; Talamini, R; Veronesi, A | 1 |
Alexander, RB; Coffey, DS; Isaacs, JT | 1 |
Carbone, A; Dal Bo, V; Francini, M; Monfardini, S; Veronesi, A | 1 |
Aso, Y; Fukushima, M; Matsuura, O; Naide, Y; Ohshima, S; Ono, Y; Ota, K; Suzuki, K; Tajima, A; Ushiyama, T | 1 |
Berenberg, J; Blumenstein, BA; Bukowski, RM; Johnson, K; O'Bryan, RM; Oishi, N; Quagliana, J; Rivkin, SE; Saiers, JH; Stephens, RL | 1 |
Frommhold, H; Jakse, G; zur Nedden, D | 1 |
6 review(s) available for arginine and Bladder Cancer
Article | Year |
---|---|
Intravesical chemotherapy of superficial bladder cancer.
Topics: Absorption; Animals; Antineoplastic Agents; BCG Vaccine; Carcinoma in Situ; Doxorubicin; Endoscopy; Ethoglucid; Humans; Hydrogen-Ion Concentration; Mitomycin; Mitomycins; Molecular Weight; Neoplasm Recurrence, Local; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1983 |
The biology and treatment of superficial bladder cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; BCG Vaccine; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystoscopy; Doxorubicin; Ethoglucid; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Prognosis; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1984 |
Rationale for intensive intravesical chemotherapy for superficial bladder cancer.
Topics: Animals; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Doxorubicin; Humans; Mitomycins; Neoplasm Recurrence, Local; Neoplasm Seeding; Neoplasms, Experimental; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1980 |
[Progress in the internist treatment of bladder tumors].
Topics: Antineoplastic Agents; BCG Vaccine; Cisplatin; Doxorubicin; Ethoglucid; Humans; Leucovorin; Methotrexate; Mitomycins; Neoplasm Metastasis; Neoplasm Recurrence, Local; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1982 |
VM 26 and VP 16-213: a comparative analysis.
Topics: Animals; Brain Neoplasms; Drug Evaluation; Etoposide; Humans; Kinetics; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms, Experimental; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1977 |
The role of epipodophyllotoxin derivatives in bladder cancer.
Topics: Combined Modality Therapy; Etoposide; Humans; Remission Induction; Teniposide; Urinary Bladder Neoplasms | 1992 |
10 trial(s) available for arginine and Bladder Cancer
Article | Year |
---|---|
Perioperative Immunonutrition Modulates Inflammatory Response after Radical Cystectomy: Results of a Pilot Randomized Controlled Clinical Trial.
Topics: Adjuvants, Immunologic; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Cystectomy; Dietary Supplements; Humans; Lymphocyte Count; Male; Neoadjuvant Therapy; Nutritional Status; Pilot Projects; Postoperative Complications; Preoperative Care; Prospective Studies; Th1 Cells; Th2 Cells; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms | 2018 |
[New antineoplastic drugs of the podophyllotoxin derivative group].
Topics: Adult; Child; Clinical Trials as Topic; Etoposide; Female; Humans; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1983 |
Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group.
Topics: Humans; Neoplasm Recurrence, Local; Prognosis; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1983 |
Cooperative studies of chemoprophylaxis after transurethral resection of bladder tumors.
Topics: Antineoplastic Agents; Carcinoma, Papillary; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Humans; Multi-Institutional Systems; Neoplasm Recurrence, Local; Prognosis; Pyridoxine; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1983 |
Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an EORTC randomized trial comparing thiotepa, an epipodophyllotoxin (VM26) and TUR alone.
Topics: Carcinoma, Transitional Cell; Clinical Trials as Topic; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Podophyllotoxin; Random Allocation; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1982 |
Chemotherapeutic management of carcinoma of the bilharzial bladder: a phase II trial with hexamethylmelamine and VM-26.
Topics: Adolescent; Adult; Aged; Altretamine; Carcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Male; Middle Aged; Podophyllotoxin; Schistosomiasis; Teniposide; Triazines; Urinary Bladder Diseases; Urinary Bladder Neoplasms | 1978 |
A comprehensive protocol for management of cancer of the bilharzial bladder.
Topics: Altretamine; Humans; Schistosomiasis; Teniposide; Urinary Bladder Diseases; Urinary Bladder Neoplasms | 1978 |
Adjuvant therapy of T1 bladder carcinoma: preliminary results of an EORTC randomized study.
Topics: Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Pathology; Podophyllotoxin; Random Allocation; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1978 |
Preliminary evaluation of VM-26: a new epipodophyllotoxin derivative, in the treatment of urogenital tumours.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Papillary; Chemotherapy, Cancer, Regional Perfusion; Clinical Trials as Topic; Drug Evaluation; Humans; Infusions, Parenteral; Leiomyosarcoma; Male; Mitosis; Neoplasm Metastasis; Podophyllotoxin; Prostatic Neoplasms; Teniposide; Teratoma; Testicular Neoplasms; Therapeutic Irrigation; Urinary Bladder Neoplasms | 1975 |
EORTC randomized trial for the adjuvant therapy of T1 bladder carcinoma.
Topics: Carcinoma, Papillary; Clinical Trials as Topic; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Podophyllotoxin; Postoperative Care; Remission, Spontaneous; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1976 |
28 other study(ies) available for arginine and Bladder Cancer
Article | Year |
---|---|
An emerging role for immuno-nutrition in patients undergoing radical cystectomy.
Topics: Arginine; Cystectomy; Humans; Immune System; Nutrition Therapy; Preoperative Period; Urinary Bladder Neoplasms | 2022 |
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5-WDR5-dependent transcriptional program.
Topics: Arginine; Cell Line, Tumor; Heat Shock Transcription Factors; Histones; Humans; Intracellular Signaling Peptides and Proteins; Lymphatic Metastasis; Protein-Arginine N-Methyltransferases; Urinary Bladder Neoplasms | 2022 |
Combined Self-Assembled Hendeca-Arginine Nanocarriers for Effective Targeted Gene Delivery to Bladder Cancer.
Topics: Administration, Intravesical; Animals; Arginine; Clathrin; DNA; Genetic Therapy; Glycosaminoglycans; Humans; Mice; Nitrogen; Peptides; Phosphates; Urinary Bladder Neoplasms | 2022 |
Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer.
Topics: Arginine; Biological Products; Chalcone; Enzyme Inhibitors; Histones; Humans; Molecular Docking Simulation; Protein-Arginine N-Methyltransferases; Urinary Bladder Neoplasms | 2022 |
Pegylated Recombinant Human Arginase 1 Induces Autophagy and Apoptosis via the ROS-Activated AKT/mTOR Pathway in Bladder Cancer Cells.
Topics: Animals; Apoptosis; Arginase; Arginine; Autophagy; Cell Line, Tumor; Female; Humans; Membrane Potential, Mitochondrial; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Neoplasm Proteins; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Recombinant Proteins; Signal Transduction; TOR Serine-Threonine Kinases; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays | 2021 |
Impact of Preoperative Immunonutrition on Perioperative Outcomes following Cystectomy.
Topics: Aged; Arginine; Cystectomy; Dietary Supplements; Female; Humans; Length of Stay; Male; Middle Aged; Patient Readmission; Postoperative Complications; Preoperative Care; Retrospective Studies; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms | 2021 |
Preoperative immunonutrition prior to radical cystectomy: a pilot study.
Topics: Aged; Arginine; Cystectomy; Female; Humans; Male; Middle Aged; Pilot Projects; Postoperative Complications; Preoperative Care; Urinary Bladder Neoplasms | 2017 |
Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers.
Topics: Anthracenes; Arginine; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Line, Tumor; DNA Replication; Enzyme-Linked Immunosorbent Assay; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Neoplasms; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Propane; Protein-Arginine N-Methyltransferases; Repressor Proteins; RNA, Small Interfering; Urinary Bladder Neoplasms | 2011 |
Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population.
Topics: Adult; Arginine; Female; Genes, p53; Genetic Predisposition to Disease; Genotype; Humans; India; Male; Middle Aged; Odds Ratio; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Proline; Risk Factors; Smoking; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms | 2010 |
Increased circulating immunosuppressive CD14(+)HLA-DR(-/low) cells correlate with clinical cancer stage and pathological grade in patients with bladder carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Arginase; Arginine; Case-Control Studies; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; HLA-DR Antigens; Humans; Interferon-gamma; Leukocytes, Mononuclear; Lipopolysaccharide Receptors; Lymphocyte Activation; Male; Middle Aged; Myeloid Cells; Neoplasm Staging; Phenotype; T-Lymphocytes; Transforming Growth Factor beta; Urinary Bladder; Urinary Bladder Neoplasms | 2011 |
Role of neutral amino acid transport and protein breakdown for substrate supply of nitric oxide synthase in human endothelial cells.
Topics: Amino Acid Transport Systems, Neutral; Amino Acids; Amino Acids, Neutral; Animals; Arginine; Biological Transport; Carcinoma; Cells, Cultured; Citrulline; Endothelium, Vascular; Glutamine; Humans; Intracellular Fluid; Membrane Transport Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Proteins; Rats; Substrate Specificity; Transfection; Umbilical Veins; Urinary Bladder Neoplasms | 2003 |
Antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on bladder cancer cell line T-24.
Topics: Antioxidants; Arginine; Ascorbic Acid; Biomarkers, Tumor; Camellia sinensis; Cell Line, Tumor; Cell Proliferation; Disease Progression; Female; Humans; In Vitro Techniques; Lysine; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Plant Extracts; Proline; Urinary Bladder Neoplasms | 2006 |
Human monocytes induce a carcinoma cell line to secrete high amounts of nitric oxide.
Topics: Arginine; Carcinoma, Transitional Cell; Coculture Techniques; Drug Combinations; Humans; Interleukin-1; Kidney Medulla; Leucine; Macrophage Activation; Monocytes; Nitric Oxide; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Solubility; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms | 1996 |
Endogenously formed nitric oxide modulates cell growth in bladder cancer cell lines.
Topics: Arginine; Cell Division; Dose-Response Relationship, Drug; Humans; Nitric Oxide; Nitric Oxide Synthase; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1999 |
Interferon regulatory factor 1 tryptophan 11 to arginine point mutation abolishes DNA binding.
Topics: Arginine; Carcinoma, Non-Small-Cell Lung; DNA-Binding Proteins; Electrophoresis; Humans; Interferon Regulatory Factor-1; Lung Neoplasms; Phosphoproteins; Point Mutation; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Transcription, Genetic; Transfection; Tryptophan; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 1999 |
Does intravesical chemotherapy prevent invasive bladder cancer?
Topics: Administration, Topical; Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Follow-Up Studies; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Random Allocation; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1984 |
Combination chemotherapy with cisplatin and VM-26 in advanced transitional cell carcinoma of the bladder.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Teniposide; Urinary Bladder Neoplasms | 1984 |
[Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
Topics: Antineoplastic Agents; Carcinoma in Situ; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Methotrexate; Mitomycin; Mitomycins; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1982 |
Combined chemotherapy in the management of metastatic bladder cancer.
Topics: Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Fluorouracil; Humans; Mitomycins; Neoplasm Metastasis; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1981 |
Single-drug chemotherapy of bladder cancer with adriamycin, VM-26 or bleomycin. A phase II multicentric, co-operative study.
Topics: Bleomycin; Doxorubicin; Humans; Neoplasm Metastasis; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1976 |
Chemotherapy of bladder tumours.
Topics: Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Papillary; Humans; Neoplasm Metastasis; Papilloma; Recurrence; Teniposide; Thiotepa; Urinary Bladder Neoplasms | 1978 |
VM 26 (4-demethyl-epipodophyllotoxin-beta-d-thenylidine glucoside) in the treatment of urinary bladder tumors.
Topics: Carcinoma, Papillary; Humans; Podophyllotoxin; Recurrence; Remission, Spontaneous; Teniposide; Time Factors; Urinary Bladder Neoplasms | 1977 |
Presurgery chemotherapy (CT) in locally advanced bladder carcinoma: a feasible and possibly effective approach.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Preoperative Care; Prospective Studies; Remission Induction; Teniposide; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 1989 |
Tumor necrosis factor enhances the in vitro and in vivo efficacy of chemotherapeutic drugs targeted at DNA topoisomerase II in the treatment of murine bladder cancer.
Topics: Animals; Antineoplastic Agents; Dactinomycin; DNA Topoisomerases, Type II; Doxorubicin; Etoposide; Female; Glycoproteins; Macrophage Activation; Mice; Recombinant Proteins; Teniposide; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms | 1987 |
Pre surgery chemotherapy in bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Preoperative Care; Teniposide; Urinary Bladder Neoplasms | 1988 |
[Use of VM-26 as a single agent in the treatment of transitional cell carcinoma of the urinary tract].
Topics: Adult; Aged; Carcinoma, Transitional Cell; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Podophyllotoxin; Teniposide; Ureteral Neoplasms; Urinary Bladder Neoplasms | 1988 |
Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.
Topics: Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Female; Humans; Kidney Neoplasms; Male; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms | 1987 |
Combined radiation and chemotherapy for locally advanced transitional cell carcinoma of the urinary bladder.
Topics: Aged; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Teniposide; Tomography, X-Ray Computed; Urinary Bladder Neoplasms | 1985 |